Ken Griffin Medical Devices

Citadel Advisors LLC

$509 Billion
Q1 2025

Stock List

Stock	Market Cap.	Holding Value (Reported)	# of Shares.	Last Trade
EW Edwards Lifesciences Corp	$47.7B	$970 Million 0.19% of portfolio	13,381,683	Q1 2025 Added 42.09%
MDT Medtronic PLC	$118B	$778 Million 0.15% of portfolio	8,661,167	Q1 2025 Added 45.08%
BSX Boston Scientific Corp	$147B	$548 Million 0.11% of portfolio	5,433,555	Q1 2025 Added 10.18%
ALGN Align Technology Inc	$15.7B	$256 Million 0.05% of portfolio	1,610,636	Q1 2025 Reduced 7.95%
ZBH Zimmer Biomet Holdings, Inc.	$20B	$231 Million 0.05% of portfolio	2,042,564	Q1 2025 Reduced 15.11%
PEN Penumbra Inc	$9.26B	$210 Million 0.04% of portfolio	784,309	Q1 2025 Added 6.81%
DXCM Dexcom Inc	$32.8B	$145 Million 0.03% of portfolio	2,127,423	Q1 2025 Reduced 50.08%
BRKR Bruker Corp	$6.24B	$52.7 Million 0.01% of portfolio	1,262,638	Q1 2025 Added 108.4%
GKOS Glaukos Corp	$4.98B	$41.4 Million 0.01% of portfolio	420,496	Q1 2025 Reduced 64.75%
TMDX Trans Medics Group, Inc.	$4.02B	$41 Million 0.01% of portfolio	609,689	Q1 2025 Added 161.74%
PODD Insulet Corp	$20.6B	$37.8 Million 0.01% of portfolio	143,950	Q1 2025 Reduced 80.26%
GMED Globus Medical Inc	$4.42B	$20.9 Million 0.0% of portfolio	285,347	Q1 2025 Reduced 88.9%
INSP Inspire Medical Systems, Inc.	$3.87B	$9.6 Million 0.0% of portfolio	60,286	Q1 2025 Added 15.0%
UFPT Ufp Technologies Inc	$1.82B	$7.83 Million 0.0% of portfolio	38,815	Q1 2025 Reduced 15.07%
LIVN Liva Nova PLC	$2.53B	$6.02 Million 0.0% of portfolio	153,212	Q1 2025 Reduced 6.59%
RXST Rx Sight, Inc.	$344M	$5.81 Million 0.0% of portfolio	230,221	Q1 2025 Reduced 76.84%
ATEC Alphatec Holdings, Inc.	$1.14B	$5.67 Million 0.0% of portfolio	559,069	Q1 2025 Added 419.25%
SNN Smith & Nephew PLC	$13.4B	$5.38 Million 0.0% of portfolio	189,488	Q1 2025 Added 105.9%
IART Integra Lifesciences Holdings Corp	$1.09B	$4.78 Million 0.0% of portfolio	217,566	Q1 2025 Added 153.82%
BFLY Butterfly Network, Inc.	$325M	$4.63 Million 0.0% of portfolio	2,030,432	Q1 2025 Reduced 8.89%
VREX Varex Imaging Corp	$334M	$4.24 Million 0.0% of portfolio	365,576	Q1 2025 Added 61.26%
FNA Paragon 28, Inc.	$1B	$4.02 Million 0.0% of portfolio	307,819	Q1 2025 Added 2,135.43%
INMD In Mode Ltd.	$1.27B	$3.96 Million 0.0% of portfolio	223,426	Q1 2025 Reduced 19.15%
AXGN Axogen, Inc.	$477M	$3.78 Million 0.0% of portfolio	204,105	Q1 2025 Added 4,500.07%
AHCO Adapt Health Corp.	$1.24B	$3.36 Million 0.0% of portfolio	310,004	Q1 2025 Added 127.27%
BIO Bio Rad Laboratories, Inc.	$6.23B	$3.12 Million 0.0% of portfolio	12,811	Q1 2025 Added 1,382.75%
CVRX Cv Rx, Inc.	$144M	$3.12 Million 0.0% of portfolio	255,043	Q1 2025 New
ESTA Establishment Labs Holdings Inc.	$1.09B	$3.06 Million 0.0% of portfolio	75,101	Q1 2025 New
ITGR Integer Holdings Corp	$3.99B	$3 Million 0.0% of portfolio	25,460	Q1 2025 Added 30.92%
CTKB Cytek Biosciences, Inc.	$482M	$2.42 Million 0.0% of portfolio	602,517	Q1 2025 Added 199.55%
TMCI Treace Medical Concepts, Inc.	$335M	$2.28 Million 0.0% of portfolio	271,272	Q1 2025 Added 3.63%
TNDM Tandem Diabetes Care Inc	$1.02B	$2.18 Million 0.0% of portfolio	114,034	Q1 2025 Reduced 13.5%
SRDX Surmodics Inc	$415M	$2.12 Million 0.0% of portfolio	69,335	Q1 2025 Added 351.02%
INGN Inogen Inc	$166M	$2.11 Million 0.0% of portfolio	296,153	Q1 2025 Added 174.65%
SIBN Si Bone, Inc.	$618M	$2.04 Million 0.0% of portfolio	145,533	Q1 2025 Reduced 34.35%
AVNS Avanos Medical, Inc.	$571M	$1.89 Million 0.0% of portfolio	132,195	Q1 2025 Added 295.58%
CERS Cerus Corp	$264M	$1.88 Million 0.0% of portfolio	1,350,806	Q1 2025 Reduced 21.9%
OFIX Orthofix Medical Inc.	$214M	$1.72 Million 0.0% of portfolio	105,495	Q1 2025 Reduced 29.88%
DCTH Delcath Systems, Inc.	$106M	$1.6 Million 0.0% of portfolio	125,552	Q1 2025 Reduced 56.65%
NPCE Neuro Pace Inc	$253M	$1.52 Million 0.0% of portfolio	123,346	Q1 2025 Added 219.49%
MYO Myomo, Inc.	$14.6M	$1.27 Million 0.0% of portfolio	263,940	Q1 2025 Added 132.77%
QTRX Quanterix Corp	$233M	$1.24 Million 0.0% of portfolio	189,960	Q1 2025 Added 5.65%
LUNG Pulmonx Corp	$98.4M	$1.24 Million 0.0% of portfolio	183,606	Q1 2025 Added 80.98%
ANIK Anika Therapeutics, Inc.	$161M	$1.03 Million 0.0% of portfolio	68,436	Q1 2025 Reduced 4.33%
BWAY Brainsway Ltd.	$214M	$968,000 0.0% of portfolio	102,310	Q1 2025 Added 218.4%
PRCT Procept Bio Robotics Corp	$2.61B	$754,000 0.0% of portfolio	12,948	Q1 2025 Reduced 82.54%
MXCT Maxcyte, Inc.	$221M	$648,000 0.0% of portfolio	237,642	Q1 2025 Reduced 37.06%
SENS Senseonics Holdings, Inc.	$228M	$584,000 0.0% of portfolio	886,225	Q1 2025 Reduced 42.46%
BVS Bioventus Inc.	$421M	$576,000 0.0% of portfolio	63,017	Q1 2025 Added 276.67%
QIPT Quipt Home Medical Corp.	$62.7M	$555,000 0.0% of portfolio	238,456	Q1 2025 Added 80.69%

Shares Options

Ken Griffin

Ken Griffin is the founder and CEO of Citadel Advisors, a successful investment firm that uses technology and data-driven approaches to investing. Griffin is known for his expertise in quantitative investing and his innovative approach to investing. He has generated strong returns for his clients over the long term.

Track Ken Griffin's portfolio

Track Ken Griffin's Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Citadel Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Citadel Advisors LLC and Ken Griffin with notifications on news.

Account